N/A
Completed N=30
Promoting Physical Activity Behavior in Persons With Multiple Sclerosis
Source: ClinicalTrials.gov NCT01572207 ↗Enrolled (actual)
30
Serious AEs
0.0%
Results posted
Jan 2015
Primary outcomePrimary: Changes From Baseline in Physical Activity Behavior — 14.36; 16.22; 33.07; 21.00 scores on a scale
Summary
The purpose of this research study is to evaluate whether tailored print material can promote physical activity and exercise, and subsequently improve quality of life and fitness levels among people with multiple sclerosis (MS). Research suggests that routine physical activity is beneficial in people with mild to moderate MS. However, people with MS may face many barriers for engaging in regular physical activity. Prescribing a home exercise program and receiving tailored motivational print material may help people engage in physical activity. Thus, the investigators hope to figure out whether tailored print material can be used as strategy to promote physical activity and improve physical function in people with MS.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Changes From Baseline in Physical Activity Behavior |
14.36; 16.22; 33.07; 21.00; 26; 23.06 | — |
| SECONDARY Changes From Baseline in Physical Fitness |
382.56; 324.12; 407.03; 321.23; 406.42; 333.09 | — |
| SECONDARY Changes From Baseline in Quality of Life |
58.57; 62.31; 53.57; 67.13; 52.29; 65.38 | — |
Eligibility Criteria
Inclusion Criteria
- A physician-confirmed diagnosis of relapsing-remitting MS
Exclusion Criteria
- Exercise more than 150 minutes per week
- Pregnant
- Metabolic or cardiopulmonary disease that puts patient at high risk for engaging in a home exercise program (patients with controlled diabetes and high blood pressure will still be considered eligible)
- Four or more falls in the past 6 months
- Be able to walk 25 feet with or without a cane
- Severe cognitive deficits
- Unable to read at a 6th grade level
- A condition besides MS that had lead to hospitalization in the past year
Data sourced from ClinicalTrials.gov (NCT01572207). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.